OBJECTIVE: To elucidate the clinical features of patients with hemorrhagic moyamoya disease (MMD) in China. METHODS: We retrospectively reviewed 471 patients with hemorrhagic MMD at Beijing Tiantan Hospital. Clinical features and radiologic findings were analyzed. RESULTS: The mean age at diagnosis was 35.3 +/- 11.5 years, with 1 peak distribution in patients from 35 to 39 years of age. The ratio of women to men was 1.2:1. Familial occurrence was 3.8%. The primary symptoms at initial presentation were intraventricular hemorrhage (42.0%), intracerebral hemorrhage (23.6%), intracerebral hemorrhage with intraventricular hemorrhage (18.3%), and subarachnoid hemorrhage (16.1%). Before the diagnosis, 68 patients experienced a second episode of bleeding. Rebleeding tends to be common within 6 years after the first bleeding (83.8%). The second bleeding episode was characterized by a change in which hemisphere bleeding occurred in 7 patients (10.3%) and by the type of bleeding in 23 patients (33.8%). Most patients presented with Suzuki stage 3 or 4 MMD (61.7%). Posterior cerebral artery involvement was observed in 28 (18.4%) patients. Forty-three intracranial aneurysms were identified in 39 patients (8.3%). CONCLUSIONS: A 1-peak pattern in age distribution and mild female dominance in sex distribution were observed in patients with hemorrhagic MMD. Rebleeding tends to be common within 6 years after the first bleeding; however, some cases of rebleeding occur after a long period. Furthermore, the second bleeding episode was characterized frequently by a change in hemisphere and the type of bleeding. Early surgical treatment in both hemispheres is recommended.
基金:
National Science and Technology Major Project of China [2006BAI01A13, 2015BAI12B04]; Beijing Municipal Science and Technology CommissionBeijing Municipal Science & Technology Commission [Z13110200680000]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81371292]; Beijing Municipal Administration of Hospitals' Mission Plan [SML20150501]
第一作者机构:[1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China;[2]China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China;[3]Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China;[4]Beijing Translat Engn Ctr 3D Printer Clin Neurosc, Beijing, Peoples R China;[5]Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China
通讯作者:
通讯机构:[1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China;[2]China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China;[3]Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China;[4]Beijing Translat Engn Ctr 3D Printer Clin Neurosc, Beijing, Peoples R China;[5]Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Ge Peicong,Zhang Qian,Ye Xun,et al.Clinical Features of Hemorrhagic Moyamoya Disease in China[J].WORLD NEUROSURGERY.2017,106:224-230.doi:10.1016/J.WNEU.2017.06.145.
APA:
Ge, Peicong,Zhang, Qian,Ye, Xun,Liu, Xingju,Deng, Xiaofeng...&Zhao, Jizong.(2017).Clinical Features of Hemorrhagic Moyamoya Disease in China.WORLD NEUROSURGERY,106,
MLA:
Ge, Peicong,et al."Clinical Features of Hemorrhagic Moyamoya Disease in China".WORLD NEUROSURGERY 106.(2017):224-230